Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Cooper

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
American Journal of Clinical Oncology|October 1, 1986
Therapy of refractory adult acute lymphoblastic leukemia with vincristine and prednisone plus tandem methotrexate and L-asparaginase. Results of a Cancer and Leukemia Group B StudyH R Terebelo, K Anderson, P H Wiernik, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamilT Y Langaee, Y Gong, H N Yarandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pumpK V Shepard, B Levin, R C Karl, et al.
Clinical Pharmacology and Therapeutics|July 11, 2008
beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertensionM A Pacanowski, Y Gong, R M Cooper-Dehoff, et al.
The Journal of Urology|April 1, 1989
Neoadjuvant treatment of stages T2 to T4 bladder cancer with cis-platinum, cyclophosphamide and doxorubicinD L McCullough, R M Cooper, L D Yeaman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomasK Antman, J Crowley, S P Balcerzak, et al.
The Pharmacogenomics Journal|September 10, 2014
Transethnic meta-analysis suggests genetic variation in the HEME pathway influences potassium response in patients treated with hydrochlorothiazideJ L Del-Aguila, R M Cooper-DeHoff, A B Chapman, et al.
Gene|December 1, 1995
Cloning and characterisation of a gene encoding a cuticle-degrading protease from the insect pathogenic fungus Metarhizium anisopliaeS L Smithson, I C Paterson, A M Bailey, et al.
The Pharmacogenomics Journal|February 13, 2013
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African AmericansJ L Del-Aguila, A L Beitelshees, R M Cooper-Dehoff, et al.
Clinical Pharmacology and Therapeutics|October 24, 2008
Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertensionA D Johnson, Y Gong, D Wang, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
American Journal of Clinical Oncology|October 1, 1986
Therapy of refractory adult acute lymphoblastic leukemia with vincristine and prednisone plus tandem methotrexate and L-asparaginase. Results of a Cancer and Leukemia Group B StudyH R Terebelo, K Anderson, P H Wiernik, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamilT Y Langaee, Y Gong, H N Yarandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pumpK V Shepard, B Levin, R C Karl, et al.
Clinical Pharmacology and Therapeutics|July 11, 2008
beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertensionM A Pacanowski, Y Gong, R M Cooper-Dehoff, et al.
The Journal of Urology|April 1, 1989
Neoadjuvant treatment of stages T2 to T4 bladder cancer with cis-platinum, cyclophosphamide and doxorubicinD L McCullough, R M Cooper, L D Yeaman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomasK Antman, J Crowley, S P Balcerzak, et al.
The Pharmacogenomics Journal|September 10, 2014
Transethnic meta-analysis suggests genetic variation in the HEME pathway influences potassium response in patients treated with hydrochlorothiazideJ L Del-Aguila, R M Cooper-DeHoff, A B Chapman, et al.
Gene|December 1, 1995
Cloning and characterisation of a gene encoding a cuticle-degrading protease from the insect pathogenic fungus Metarhizium anisopliaeS L Smithson, I C Paterson, A M Bailey, et al.
The Pharmacogenomics Journal|February 13, 2013
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African AmericansJ L Del-Aguila, A L Beitelshees, R M Cooper-Dehoff, et al.
Clinical Pharmacology and Therapeutics|October 24, 2008
Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertensionA D Johnson, Y Gong, D Wang, et al.
Pageof 13